Senior insider sale
EVP, Europe Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$10.47M
335.80K shares
What this filing means
DANIELL RICHARD plans to sell 335.80K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $10.47M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/4/2026ACC: 0001973379-26-000082
Officer· EVP, Europe Commercial
Since Mar 2026
335.80K
Shares to sell
$10.47M
Approx. market value
91.34K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
SHARES FROM ROLLOVER
COMPENSATION
3/3/2026
37.37KRESTRICTED SHARE AWARD
COMPENSATION
3/4/2022
53.97KTotal acquired91.34K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/3/2026 | SHARES FROM ROLLOVER COMPENSATION | 37.37K | — |
3/4/2022 | RESTRICTED SHARE AWARD COMPENSATION | 53.97K | — |
| Total | 91.34K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
128.99K
Market value
$4.17M
3/3/2026
—Completed
Units to sell
115.47K
Market value
$3.31M
12/9/2025
Planned — Approximate Date
NYSEPlanned
Units to sell
91.34K
Market value
$2.98M
3/4/2026
Total
Units
335.80K
Value
$10.47M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/3/2026 | 128.99K | $4.17M | — | Completed |
12/9/2025 | 115.47K | $3.31M | — | Completed |
| Planned — Approximate Date | ||||
3/4/2026 | 91.34K | $2.98M | NYSE | Planned |
| Total | 335.80K | $10.47M | ||